BlackRock’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $636M | Buy |
|
|||||
|
2025
Q2 | $396M | Sell |
|
|||||
|
2025
Q1 | $363M | Sell |
|
|||||
|
2024
Q4 | $389M | Buy |
|
|||||
|
2024
Q3 | $361M | Buy |
|
|||||
|
2024
Q2 | $277M | Buy |
|
|||||
|
2024
Q1 | $283M | Buy |
|
|||||
|
2023
Q4 | $292M | Buy |
|
|||||
|
2023
Q3 | $142M | Sell |
|
|||||
|
2023
Q2 | $103M | Buy |
|
|||||
|
2023
Q1 | $67.4M | Buy |
|
|||||
|
2022
Q4 | $108M | Buy |
|
|||||
|
2022
Q3 | $86.7M | Buy |
|
|||||
|
2022
Q2 | $4.89M | Sell |
|
|||||
|
2022
Q1 | $37.8M | Sell |
|
|||||
|
2021
Q4 | $33.2M | Sell |
|
|||||
|
2021
Q3 | $43.9M | Buy |
|
|||||
|
2021
Q2 | $65.3M | Buy |
|
|||||
|
2021
Q1 | $66.9M | Buy |
|
|||||
|
2020
Q4 | $81.2M | Buy |
|
|||||
|
2020
Q3 | $57.2M | Sell |
|
|||||
|
2020
Q2 | $62.3M | Buy |
|
|||||
|
2020
Q1 | $38M | Sell |
|
|||||
|
2019
Q4 | $58.7M | Buy |
|
|||||
|
2019
Q3 | $41.9M | Buy |
|
|||||
|
2019
Q2 | $42M | Buy |
|
|||||
|
2019
Q1 | $41.9M | Sell |
|
|||||
|
2018
Q4 | $41.8M | Buy |
|
|||||
|
2018
Q3 | $33.3M | Buy |
|
|||||
|
2018
Q2 | $23.4M | Buy |
|
|||||
|
2018
Q1 | $7.68M | Buy |
|
|||||
|
2017
Q4 | $10.5M | Buy |
|